Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
More than 1 in 6 adults who survive revascularization for peripheral arterial disease have an unplanned readmission within 30 days, according to a study in the Annals of Internal Medicine.
U.S. researchers used the Nationwide Readmissions Database from 2017 to identify nearly 62,000 patients who underwent either surgical or endovascular revascularization for peripheral arterial disease and survived to discharge.
The 30-day unplanned readmission rate was 18%, which is close to the readmission rate after myocardial infarction. The largest contributor to readmissions was periprocedural complications, most often infections. The median cost per readmission was $11,000.
The authors conclude: “Future strategies to reduce the need for readmission should prioritize improving postdischarge patient care for … high-risk patients.”